GB9407135D0
(en )
1994-06-01
Treatment of osteoporosis
ZA969520B
(en )
1997-05-14
Use of epinastine for the treatment of pain
HUP9901089A3
(en )
2000-03-28
Medical splint
EP0831845A4
(en )
1998-12-02
Diphosphonate derivatives of therapeutic agents
ZA983764B
(en )
1998-11-06
Plant extracts for treatment of increased bone resorption
AU4440496A
(en )
1996-08-22
Use of src SH2 specific compounds to treat a bone resorption disease
AU4777896A
(en )
1996-08-27
Use of low dose amount of spironolactone for treatment of cardiovascular disease
IL119894A0
(en )
1997-03-18
Thiazolidine derivatives for treatment of osteoporosis
AU6328696A
(en )
1996-12-30
Treatment of hemoglobinopathies
GB2284205B
(en )
1998-04-29
Treatment of agricultural waste
HUP9802423A3
(en )
2000-11-28
Combined therapeutical treatment of hyperproliferative diseases
HU9502426D0
(en )
1995-10-30
Compounds of pharmaceutical activity
PL323728A1
(en )
1998-04-14
Pesticidal compounds of substituted 3-arylpyrazoles
HUP9901303A3
(en )
2001-04-28
A pharmaceutical composition for the treatment of autoimmune diseases
PL327538A1
(en )
1998-12-21
Novel compounds of analgesic activity
ZA96314B
(en )
1997-07-16
Use of sertraline to treat cancer patients
EP1084108A4
(en )
2005-01-12
Spla 2? inhibitor compounds for treatment of disease
ZA961001B
(en )
1996-08-13
Use of src SH2 specific compounds to treat a bone resorption disease
AU4440596A
(en )
1996-08-22
Use of hcp SH2 specific compounds to enhance erythropoiesis
GB9502136D0
(en )
1995-03-22
Treatment of waste
EP0783891A4
(en )
2002-04-17
Remedy for bone diseases
AU1931895A
(en )
1995-10-03
Treatment of graft-versus-host disease
GB9525828D0
(en )
1996-02-21
Use of hetarylacetic acid derivatives
AU9166598A
(en )
1999-03-29
Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
GB9520495D0
(en )
1995-12-13
Treatment of medical conditions